Medical News

RSS

Regis Technologies' 4-Aminopyridine manufacturing facility receives FDA's EIR and PAI approval

Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) stating that Regis passed the FDA’s pre-approval inspection (PAI) for its manufacture of 4-Aminopyridine the active ingredient in Ampyra™.

29 Jan 2010

New Jersey surgeons perform multi-process procedure for spinal cord injuries

The Plastic Surgery Center today announced that in a highly rare procedure for spinal cord injuries, a New Jersey medical team led by Dr. Matthew Kaufman enabled a 51-year-old man to breathe on his own - without a ventilator - for the first time since becoming paralyzed.

29 Jan 2010

Sports Medicine Clinic offers PRP therapy to heal injured ligaments, tendons and muscles

The Sports Medicine Clinic at the University of Virginia Health System is using a cutting-edge therapy called platelet rich plasma (PRP) to help heal injured ligaments, tendons and muscles.

29 Jan 2010

When it comes to marital satisfaction, pronouns matter

In contrast, couples who emphasized their "separateness" by using pronouns such as "I," "me" and "you" were found to be less satisfied in their marriages. This was especially true for older couples. Their use of separateness pronouns was most strongly linked to unhappy marriages, according to the study.

29 Jan 2010

Researchers reveal major shifts in structure of scientific research

How has the structure of scientific research changed over the past decade? A team of researchers from Ume- University, Sweden, and the University of Washington, USA, aims to answer this question and others in a study published on January 27th in the online, open-access journal PLoS ONE.

29 Jan 2010

One in five nursing homes receive poor quality ratings, analysis finds

USA Today: "One in five of the nation's 15,700 nursing homes have consistently received poor ratings for overall quality, a USA Today analysis of new government data finds. More than a quarter-million patients live in homes given another set of low scores within the past year, according to data released today by Medicare, which first released the star ratings of the nation's nursing homes in late 2008.

29 Jan 2010

Watson Pharmaceuticals acquires Eden Biopharm Group for approximately $15M

Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.

29 Jan 2010

FDA approves LPI's Perindopril Erbumine tablets

Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Perindopril Erbumine tablets, 2mg, 4mg and 8mg. Commercial shipments of the product will commence shortly.

29 Jan 2010

State budget news from Kansas, Massachusetts and Idaho

Kansas Health Institute reports that the recession is crippling Kansas' safety-net system. "The Kansas unemployment insurance system is virtually broke at a time when Department of Labor officials say they need about $15 million a week to pay benefits to out-of-work Kansans.

29 Jan 2010

Study shows doctors cut back their workload for fear of malpractice lawsuits

A new study shows that the number of hours physicians spend on the job each week is influenced by the fear of malpractice lawsuits.

29 Jan 2010

Obama appeals for health reform despite recent setbacks

The New York Times reports that "after spending 2009 emphasizing that a health care overhaul was his top domestic priority, Mr. Obama gave it much less prominence in his [State of the Union] address. He did not mention it until more than half an hour in — a sign of how imperiled the bill has become."

29 Jan 2010

iPierian receives UK patent for induced pluripotent stem cell technology

iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced that the Intellectual Property Office in the United Kingdom has issued a Notification of Grant to iPierian for UK patent No. GB2450603, its first patent related to induced pluripotent stem cell (iPSC) technology.

29 Jan 2010

NovaSom Diagnostic System approved for diagnostic evaluation of adults with OSA

Some 18-20 million Americans are at risk for Obstructive Sleep Apnea (OSA) and of those, only 5 to 10 percent have been diagnosed. Studies prove that fatality is a major risk of undiagnosed and untreated OSA; however, once detected, OSA can be readily and successfully treated.

29 Jan 2010

Findings demonstrate direct correlation between improved air quality and pediatric ear infections

A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.

28 Jan 2010

People with early-stage lung cancer may double their chances of surviving by giving up smoking

People with early-stage lung cancer may double their chances of surviving for longer than five years by giving up smoking, UK scientists have found.

28 Jan 2010

Increased cost sharing may hurt seniors' health care

Cost sharing and increased co-pays, even if it's just a few dollars, can lead seniors to put off visits to the doctor and result in increased hospital admissions and longer hospital stays, according to a new study.

28 Jan 2010

Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

Conatus Pharmaceuticals Inc. announced today the initiation of a Phase II clinical trial evaluating CTS-1027 in combination with pegylated interferon (Pegasys®) and ribavirin (Copegus®) in refractory HCV patients. Antiviral activity, safety and tolerability of the triple combination will be assessed after up to 48 weeks of therapy.

28 Jan 2010

Medical News

Regis Technologies' 4-Aminopyridine manufacturing facility receives FDA's EIR and PAI approval

New Jersey surgeons perform multi-process procedure for spinal cord injuries

Sports Medicine Clinic offers PRP therapy to heal injured ligaments, tendons and muscles

When it comes to marital satisfaction, pronouns matter

Researchers reveal major shifts in structure of scientific research

One in five nursing homes receive poor quality ratings, analysis finds

Watson Pharmaceuticals acquires Eden Biopharm Group for approximately $15M

FDA approves LPI's Perindopril Erbumine tablets

State budget news from Kansas, Massachusetts and Idaho

Study shows doctors cut back their workload for fear of malpractice lawsuits

Obama appeals for health reform despite recent setbacks

iPierian receives UK patent for induced pluripotent stem cell technology

NovaSom Diagnostic System approved for diagnostic evaluation of adults with OSA

Findings demonstrate direct correlation between improved air quality and pediatric ear infections

People with early-stage lung cancer may double their chances of surviving by giving up smoking

Increased cost sharing may hurt seniors' health care

Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

Mcdonnell says Democratic agenda, including health care effort, is too expensive

Rotavirus vaccine could save millions of children in developing countries, studies find

Life Technologies collaborates with Ignite Institute to create genomic sequencing center

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News